Notably, this study specifically excluded patients with PCOS, and used a GnRH agonist protocol in over 70% of cases, limiting the applicability of the data to the contemporary practice of IVF in patients with PCOS (61). Here, GNRH1 is linked to polycystic ovary syndrome.